These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 316642)

  • 1. Regulation of ribonucleotide reductase activity and its possible exploitation in chemotherapy.
    Witt L; Yap T; Blakley RL
    Adv Enzyme Regul; 1978; 17():157-71. PubMed ID: 316642
    [No Abstract]   [Full Text] [Related]  

  • 2. 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
    Cory AH; Samano V; Robins MJ; Cory JG
    Biochem Pharmacol; 1994 Jan; 47(2):365-71. PubMed ID: 8304981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic preparation of the 5'-triphosphates of 2'-deoxytubercidin, 2'-deoxytoyocamycin, and 2'-deoxyformycin and the allosteric effects of these nucleotides on ribonucleotide reductase.
    Brinkley SA; Lewis A; Critz WJ; Witt LL; Townsend LB; Blakley RL
    Biochemistry; 1978 Jun; 17(12):2350-6. PubMed ID: 687385
    [No Abstract]   [Full Text] [Related]  

  • 4. From RNA to DNA, why so many ribonucleotide reductases?
    Reichard P
    Science; 1993 Jun; 260(5115):1773-7. PubMed ID: 8511586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of ribonucleotide reduction.
    Reichard P
    Trends Biochem Sci; 1997 Mar; 22(3):81-5. PubMed ID: 9066257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a cultured human T-cell line with genetically altered ribonucleotide reductase activity. Model for immunodeficiency.
    Waddell D; Ullman B
    J Biol Chem; 1983 Apr; 258(7):4226-31. PubMed ID: 6339493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate and effector binding to ribonucleoside triphosphate reductase of Lactobacillus leichmannii.
    Chen AK; Bhan A; Hopper S; Abrams R; Franzen JS
    Biochemistry; 1974 Feb; 13(4):654-61. PubMed ID: 4811061
    [No Abstract]   [Full Text] [Related]  

  • 8. Current ideas on the chemical mechanism of ribonucleotide reductases.
    Ashley GW; Stubbe J
    Pharmacol Ther; 1985; 30(3):301-29. PubMed ID: 3916287
    [No Abstract]   [Full Text] [Related]  

  • 9. Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents.
    Cory AH; He AW; Cory JG
    Adv Enzyme Regul; 1998; 38():3-18. PubMed ID: 9762343
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture.
    Matsumoto M; Tihan T; Cory JG
    Cancer Chemother Pharmacol; 1990; 26(5):323-9. PubMed ID: 2208572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acid related compounds. 74. Synthesis and biological activity of 2'(and 3')-deoxy-2'(and 3')-methylenenucleoside analogues that function as mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase and/or ribonucleotide reductase.
    Robins MJ; Samano V; Zhang W; Balzarini J; De Clercq E; Borchardt RT; Lee Y; Yuan CS
    J Med Chem; 1992 Jun; 35(12):2283-93. PubMed ID: 1613752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of naturally occurring purine deoxyribonucleosides.
    Henderson JF; Scott FW; Lowe JK
    Pharmacol Ther; 1980; 8(3):573-604. PubMed ID: 6247724
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenosylcobalamin analogues as inhibitors of ribonucleotide reductase and vitamin B12 transport.
    Jacobsen DW; DiGirolamo PM; Huennekens FM
    Mol Pharmacol; 1975 Mar; 11(2):174-84. PubMed ID: 1168310
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine deaminase impairment and ribonucleotide reductase in human cells.
    Elford HL; Lin AL
    Ann N Y Acad Sci; 1985; 451():98-112. PubMed ID: 3907454
    [No Abstract]   [Full Text] [Related]  

  • 15. Ribonucleoside 5'-thiodiphosphates as substrates for Escherichia coli ribonucleotide reductase.
    von Döbeln U; Eckstein F
    Eur J Biochem; 1974 Apr; 43(2):215-20. PubMed ID: 4151721
    [No Abstract]   [Full Text] [Related]  

  • 16. The interaction of adeninylalkylcobalamins with ribonucleotide reductase.
    Sando GN; Grant ME; Hogenkamp HP
    Biochim Biophys Acta; 1976 Mar; 428(1):228-32. PubMed ID: 1260019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme B12-dependent ribonucleotide reductase: evidence for the participation of five cysteine residues in ribonucleotide reduction.
    Booker S; Licht S; Broderick J; Stubbe J
    Biochemistry; 1994 Oct; 33(42):12676-85. PubMed ID: 7918494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of ribonucleotide reduction in nucleotide-permeable hamster cells.
    Lewis WH; Kuzik BA; Wright JA
    J Cell Physiol; 1978 Mar; 94(3):287-98. PubMed ID: 621224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductases and radical reactions.
    Fontecave M
    Cell Mol Life Sci; 1998 Jul; 54(7):684-95. PubMed ID: 9711234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
    Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
    Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.